To include your compound in the COVID-19 Resource Center, submit it here.

WuXi Biologics to manufacture NBE’s ADC for clinical trials

WuXi Biologics will manufacture NBE-Therapeutics’ lead antibody-drug

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE